MedTrace Logo

Hsv 1 and 2 Gowey Protocol Versus Placebo

NCT01477879 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2011-11-23

No results posted yet for this study

Summary

This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.

Conditions

  • Herpes

Interventions

OTHER

Versabase gel with sarracenia purpurea 20% liquid extract

Topical application of gel/plant mix to lesions

OTHER

placebo (versabase gel only)

versabase gel only

Sponsors & Collaborators

  • Naturopaths International

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01477879 on ClinicalTrials.gov